Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy Mar 21, 2024
Child Deaths Rise in U.S.; Water Beads Warning; Cancer Studies Retracted Health news and commentary from around the Web gathered by MedPage Today staff Mar 21, 2024
Who Should Pay to Clean Up 'Forever Chemicals'? Not us, representatives of water utilities and landfills say at a Senate hearing Mar 20, 2024
Lenvatinib-Pembrolizumab Combo Misses on Survival in Endometrial Cancer Trial Combination in first-line fails to improve progression-free, overall survival versus chemotherapy Mar 20, 2024
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer Use of the PARP inhibitor improved PFS by 19.4 months versus placebo in phase II study Mar 19, 2024
EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban New rule would prohibit chrysotile asbestos Mar 19, 2024
How Often Should Immunocompromised People Get a COVID Booster? Experts say about every 6 months, but that should be individualized Mar 18, 2024
Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says Mar 18, 2024
Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer Dostarlimab and pembrolizumab regimens should be incorporated into practice "as of yesterday" Mar 17, 2024
EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
New PD-1 Inhibitor Approved for Esophageal Cancer Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
FDA Panel Endorses Imetelstat for MDS-Related Anemia By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
Banning Gain-of-Function Research Would Do Far More Harm Than Good A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
FDA OKs First Interchangeable Biosimilars for Denosumab New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pond Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubt "Every month that you're not pregnant feels like grief" Mar 05, 2024
Novel Therapy Promising for Radiation-Induced Oral Mucositis No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024
Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC Local control in 91% of cases at 1 year in small prospective trial Mar 01, 2024
Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results One first-line regimen led to worse OS, while another offers an additional option Mar 01, 2024
New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Results News, features, and commentary about cancer-related issues Mar 01, 2024
Robotic Surgery for Pancreatic Tumors Proves Safe, Feasible in Experienced Hands Shorter stays, faster surgeries, and less blood loss versus open surgery in Chinese study Feb 29, 2024
Oregon Pathologist Reportedly Missed Cancer Diagnoses One patient received the news that she had cancer a year after breast biopsy Feb 27, 2024
Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors Objective response rate of 37.7% in patients with various solid tumors in phase I study Feb 26, 2024
Can Artificial Intelligence Improve Prior Authorization? Possibly, but "complete transparency" about its use would be needed, expert says Feb 23, 2024
Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning News, features, and commentary about cancer-related issues Feb 23, 2024
Faster Cures, More Genetic Treatments: A Q&A With NIH's Joni Rutter The NCATS Biomedical Data Translator is giving researchers ideas for new disease therapies Feb 23, 2024
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Male Fertility Problems in the Family Linked to Cancer Risk Low sperm levels were tied to specific cancers in family members Feb 22, 2024
Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain News, features, and commentary about cancer-related issues Feb 16, 2024
Cancer Patients Caught in the Crosshairs of Hospital Consolidation Policymakers must rein in anti-competitive tactics Feb 16, 2024
U.S. Probes Role of Supply Chain Middlemen in Generic Shortages Goal: identify "root causes" and "potential solutions" Feb 15, 2024
Oldest Patient 'Cured' of HIV Still in Remission 5 Years After Transplant for AML But it's unlikely stem cell transplants will ever be large-scale cure for HIV, says expert Feb 14, 2024
New First-Line Option for Pancreatic Cancer Approved Liposomal irinotecan-based regimen gets FDA greenlight for metastatic disease Feb 13, 2024
Oncologists Risk Self-Referral Violations Over Medicare Mail-Order Drug Rule New interpretation of Stark law excludes distribution of oral oncology drugs by mail Feb 12, 2024
